127 related articles for article (PubMed ID: 32423324)
41. [Colon cancer during the coronavirus pandemic – recovery from COVID-19 pneumonia of an elderly woman with multiple co-morbidities].
Pordány B; Herczeg G; Máté M
Orv Hetil; 2020 Jun; 161(25):1059-1062. PubMed ID: 32516124
[TBL] [Abstract][Full Text] [Related]
42. COVID-19: the use of immunotherapy in metastatic lung cancer.
Davis AP; Boyer M; Lee JH; Kao SC
Immunotherapy; 2020 Jun; 12(8):545-548. PubMed ID: 32349579
[No Abstract] [Full Text] [Related]
43. Rapid onset type-1 diabetes and diabetic ketoacidosis secondary to nivolumab immunotherapy: a review of existing literature.
Abdullah HMA; Elnair R; Khan UI; Omar M; Morey-Vargas OL
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31451458
[TBL] [Abstract][Full Text] [Related]
44. [Explore the Optimal Resolvent of Medical Needs and Mental Health for Patients with Lung Cancer during Epidemic Novel Coronavirus Pneumonia].
Xu H; Yang K; Yang G; Yang L; Mi Y; Cui X; Yang M; Wang D; Wang Y
Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):247-254. PubMed ID: 32316712
[TBL] [Abstract][Full Text] [Related]
45. Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Firouzabadi FD; Firouzabadi MD; Ghalehbaghi B; Jahandideh H; Roomiani M; Goudarzi S
Med Hypotheses; 2020 Oct; 143():110067. PubMed ID: 32634735
[No Abstract] [Full Text] [Related]
46. Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
Pala L; Conforti F; Cocorocchio E; Ferrucci P; De Pas MT; Stucchi S; Repetto M; Saponara M; Queirolo P
Cancer Invest; 2021 Jan; 39(1):9-14. PubMed ID: 33125301
[TBL] [Abstract][Full Text] [Related]
47. A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature.
Dai Y; Liu S; Zhang Y; Li X; Zhao Z; Liu P; Du Y
J Med Case Rep; 2021 Feb; 15(1):41. PubMed ID: 33522942
[TBL] [Abstract][Full Text] [Related]
48. Should the search for COVID-19 become part of the work-up of incidental thromboembolism? A near-missed COVID-19 diagnosis.
Franceschini M; Carlin M; Porta M; Brizzi MF
Intern Emerg Med; 2020 Nov; 15(8):1587-1589. PubMed ID: 32710288
[No Abstract] [Full Text] [Related]
49. Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers.
Luo J; Rizvi H; Egger JV; Preeshagul IR; Wolchok JD; Hellmann MD
Cancer Discov; 2020 Aug; 10(8):1121-1128. PubMed ID: 32398243
[TBL] [Abstract][Full Text] [Related]
50. Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.
Serzan MT; Kumar PN; Atkins MB
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32434789
[TBL] [Abstract][Full Text] [Related]
51. Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.
Shen C; Li Q; Wei Y; Li Y; Li J; Tao J
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33303577
[TBL] [Abstract][Full Text] [Related]
52. Delayed Metastatic Polypoid Nodular Melanoma Diagnosis During COVID-19 Pandemic, Successful Treatment With Surgery and Nivolumab.
Bradu S; Siegel D; Loyal J; Leaf A; Kurtti A; Alapati U; Jagdeo J
J Drugs Dermatol; 2021 Dec; 20(12):1343-1345. PubMed ID: 34898148
[TBL] [Abstract][Full Text] [Related]
53. Triple-negative breast cancer patients with isolated lung metastases and concomitant COVID-19 infection; does cytokine storm result in better efficacy?
Altundag K
J BUON; 2020; 25(3):1664. PubMed ID: 32862620
[No Abstract] [Full Text] [Related]
54. Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
Ruíz-Quiñonez JA; Guzmán-Priego CG; Nolasco-Rosales GA; Tovilla-Zarate CA; Flores-Barrientos OI; Narváez-Osorio V; Baeza-Flores GDC; Gonzalez-Castro TB; López-Brito CR; Denis-García CA; Pérez-García A; Juárez-Rojop IE
PLoS One; 2021; 16(2):e0245394. PubMed ID: 33606711
[TBL] [Abstract][Full Text] [Related]
55. Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report.
Inadomi K; Kumagai H; Arita S; Tsuruta N; Takayoshi K; Mishima K; Ota SI; Tanaka M; Okumura Y; Sagara K; Nio K; Nakano M; Uchi H; Yamamoto H; Ariyama H; Kusaba H; Niiro H; Oda Y; Akashi K; Baba E
Medicine (Baltimore); 2016 Jul; 95(29):e4283. PubMed ID: 27442668
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 and immune checkpoint inhibitors: initial considerations.
Sullivan RJ; Johnson DB; Rini BI; Neilan TG; Lovly CM; Moslehi JJ; Reynolds KL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32434790
[TBL] [Abstract][Full Text] [Related]
57. Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report.
Anastasopoulou A; Gkoufa A; Diamantopoulos P; Kazanas S; Eliadi I; Samarkos M; Gogas H
Immunotherapy; 2022 Sep; 14(13):1015-1020. PubMed ID: 35852114
[TBL] [Abstract][Full Text] [Related]
58. Impact of Covid-19 on the management of patients with metastatic melanoma.
Welti M; Cheng PF; Mangana J; Levesque MP; Dummer R; Imhof L
Oncotarget; 2022 Dec; 13():1370-1379. PubMed ID: 36580495
[TBL] [Abstract][Full Text] [Related]
59. Spotting the pigmented 'Monster': primary melanoma in urinary bladder.
Singh V; Gupta K; Dewana S; Mandal AK
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31874845
[No Abstract] [Full Text] [Related]
60. [A woman in her eighties with chest pain during immunotherapy for melanoma].
Karlsen TLS; Karlsen J; Mo R; Hammer T
Tidsskr Nor Laegeforen; 2021 Sep; 141(2021-12):. PubMed ID: 34505493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
